glp-1 medication thibodaux Low-Dose and Microdose for Longevity – GLP-1 medications are being praised

doi: 10.1016/j.micpath.2020.104645 154 ChoiWChoeSLinJBorchersMTKosmiderBVassalloRet al

"Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man." J Clin Endocrinol Metab

No statement here is a guarantee of any outcome

Aligned with earlier findings, semaglutide treatment at dosages from 0.5 mg to 2 mg weekly demonstrated variable efficacy, from merely preventing further weight gain in Patient 1 to achieving weight loss of up to 14.4% and 11% relative to baseline, in Patient 2 and Patient 3, respectively

As the major mechanosensors in bone, osteocytes couple mechanical signals with systemic hormones (284)